Sign Out
Epilepsy: TOPAMAX is indicated as monotherapy in patients with newly diagnosed epilepsy or for conversion to monotherapy in patients with epilepsy.
TOPAMAX is indicated as adjunctive therapy for adults and children (aged 2 and above) with partial onset seizures or generalized tonic-clonic seizures.
TOPAMAX is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with Lennox Gastaut syndrome.
Migraine: TOPAMAX is indicated in adults for the prophylaxis of migraine headache. The usefulness of TOPAMAX in the acute treatment of migraine headache has not been studied.
